These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 38376772
1. Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies. Gao J, Wang Y, Xiong H, Zhao S, He M, He M, Pan H. Cardiovasc Toxicol; 2024 Feb; 24(2):171-183. PubMed ID: 38376772 [Abstract] [Full Text] [Related]
2. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies. Mu BX, Li Y, Ye N, Liu S, Zou X, Qian J, Wu C, Zhuang Y, Chen M, Zhou JY. J Ethnopharmacol; 2024 Jan 30; 319(Pt 3):117342. PubMed ID: 37879505 [Abstract] [Full Text] [Related]
3. Efficacy of Danlou tablet on myocardial ischemia/ reperfusion injury assessed by network pharmacology and experimental verification. Ye Y, Xiaoyang C, Junkai Y, Yueyao HU, Wei W. J Tradit Chin Med; 2024 Feb 30; 44(1):131-144. PubMed ID: 38213248 [Abstract] [Full Text] [Related]
4. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke. Zhao S, Zhang P, Yan Y, Xu W, Li J, Wang L, Wang N, Huang Y. J Ethnopharmacol; 2023 Aug 10; 312():116507. PubMed ID: 37080367 [Abstract] [Full Text] [Related]
5. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. Yao T, Wang Q, Han S, Lu Y, Xu Y, Wang Y. Biomed Res Int; 2022 Aug 10; 2022():9214589. PubMed ID: 35837376 [Abstract] [Full Text] [Related]
6. Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification. Zhu X, Li Y, Wang X, Huang Y, Mao J. Medicine (Baltimore); 2023 Apr 25; 102(17):e33360. PubMed ID: 37115092 [Abstract] [Full Text] [Related]
7. Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study. Yang J, Gu J, Shen Y, Cao L, Zhou H, Zhu W. Cancer Pathog Ther; 2023 Oct 25; 1(4):229-237. PubMed ID: 38327605 [Abstract] [Full Text] [Related]
8. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia. Ye M, Liu G, Yang Y, Yang H, Ren J, Chen W, Gao Z. Sci Rep; 2023 Oct 13; 13(1):17385. PubMed ID: 37833363 [Abstract] [Full Text] [Related]
9. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation. Wang YC, Hui JR, Xiao G, Ma QL. Chin J Integr Med; 2023 Mar 13; 29(3):244-252. PubMed ID: 36044117 [Abstract] [Full Text] [Related]
10. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W. Drug Des Devel Ther; 2021 Mar 13; 15():3255-3276. PubMed ID: 34349502 [Abstract] [Full Text] [Related]
11. Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Zhao M, Feng L, Li W. Drug Des Devel Ther; 2024 Mar 13; 18():4529-4550. PubMed ID: 39399124 [Abstract] [Full Text] [Related]
12. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification]. Hu YJ, Wei LY, Zhao J, Zhu QF, Meng ZY, Meng JJ, Chen JJ, Xu LY, Zhou YY, Han YL. Zhongguo Zhong Yao Za Zhi; 2023 Apr 13; 48(8):2222-2232. PubMed ID: 37282910 [Abstract] [Full Text] [Related]
13. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation. Lu S, Sun X, Zhou Z, Tang H, Xiao R, Lv Q, Wang B, Qu J, Yu J, Sun F, Deng Z, Tian Y, Li C, Yang Z, Yang P, Rao B. Front Immunol; 2023 Apr 13; 14():1235575. PubMed ID: 37799727 [Abstract] [Full Text] [Related]
14. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology. Tu H, Feng Y, Wang W, Zhou H, Cai Q, Feng Y. Chem Biol Drug Des; 2024 Jan 13; 103(1):e14413. PubMed ID: 38040415 [Abstract] [Full Text] [Related]
15. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huang-Qi-Gui-Zhi-Wu-Wu decoction against deep vein thrombosis. Fan W, Lan S, Yang Y, Liang J. J Orthop Surg Res; 2023 Jun 30; 18(1):475. PubMed ID: 37391801 [Abstract] [Full Text] [Related]
16. Observational study on the potential mechanism of Sanao decoction in the treatment of asthma based on network pharmacology and molecular docking. Chen W, Liu Q, Gao X, Geng Y, Kan H. Medicine (Baltimore); 2024 Mar 22; 103(12):e37592. PubMed ID: 38518018 [Abstract] [Full Text] [Related]
17. Exploring the mechanism of Astragali radix for promoting osteogenic differentiation based on network pharmacology, molecular docking, and experimental validation. Tian Z, Li Y, Wang X, Cui K, Guo J, Wang M, Hao Y, Zhang F. Chem Biol Drug Des; 2023 Dec 22; 102(6):1489-1505. PubMed ID: 37690812 [Abstract] [Full Text] [Related]
18. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification. Qinjun Y, Dandan Y, Hui W, Yating G, Xinheng W, Di WU, Jiabing T, Chuanbo W, Zegeng LI. J Tradit Chin Med; 2024 Aug 22; 44(4):770-783. PubMed ID: 39066538 [Abstract] [Full Text] [Related]
19. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation. Pan J, Tang J, Gai J, Jin Y, Tang B, Fan X. Medicine (Baltimore); 2023 May 26; 102(21):e33877. PubMed ID: 37233418 [Abstract] [Full Text] [Related]
20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Wang Y, Chu F, Lin J, Li Y, Johnson N, Zhang J, Gai C, Su Z, Cheng H, Wang L, Ding X. J Ethnopharmacol; 2021 Oct 28; 279():114399. PubMed ID: 34246740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]